nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCB1—Mitomycin—urinary bladder cancer	0.147	0.206	CbGbCtD
Levetiracetam—ABCC2—Carboplatin—urinary bladder cancer	0.11	0.155	CbGbCtD
Levetiracetam—ABCC2—Cisplatin—urinary bladder cancer	0.094	0.132	CbGbCtD
Levetiracetam—ABCC2—Etoposide—urinary bladder cancer	0.0924	0.13	CbGbCtD
Levetiracetam—ABCC2—Doxorubicin—urinary bladder cancer	0.063	0.0887	CbGbCtD
Levetiracetam—ABCC2—Methotrexate—urinary bladder cancer	0.0611	0.0859	CbGbCtD
Levetiracetam—ABCB1—Gemcitabine—urinary bladder cancer	0.0422	0.0594	CbGbCtD
Levetiracetam—ABCB1—Cisplatin—urinary bladder cancer	0.0307	0.0431	CbGbCtD
Levetiracetam—ABCB1—Etoposide—urinary bladder cancer	0.0301	0.0424	CbGbCtD
Levetiracetam—ABCB1—Doxorubicin—urinary bladder cancer	0.0205	0.0289	CbGbCtD
Levetiracetam—ABCB1—Methotrexate—urinary bladder cancer	0.0199	0.028	CbGbCtD
Levetiracetam—SV2A—prostate gland—urinary bladder cancer	0.016	0.22	CbGeAlD
Levetiracetam—SV2A—seminal vesicle—urinary bladder cancer	0.0135	0.186	CbGeAlD
Levetiracetam—SV2A—urethra—urinary bladder cancer	0.0107	0.147	CbGeAlD
Levetiracetam—SV2A—vagina—urinary bladder cancer	0.00789	0.109	CbGeAlD
Levetiracetam—SV2A—lymph node—urinary bladder cancer	0.00511	0.0703	CbGeAlD
Levetiracetam—ABCC2—prostate gland—urinary bladder cancer	0.00358	0.0493	CbGeAlD
Levetiracetam—CACNA1B—lymph node—urinary bladder cancer	0.00353	0.0486	CbGeAlD
Levetiracetam—ABCC2—renal system—urinary bladder cancer	0.00244	0.0336	CbGeAlD
Levetiracetam—ABCC2—female reproductive system—urinary bladder cancer	0.00195	0.0269	CbGeAlD
Levetiracetam—ABCB1—prostate gland—urinary bladder cancer	0.00129	0.0177	CbGeAlD
Levetiracetam—ABCC2—lymph node—urinary bladder cancer	0.00114	0.0157	CbGeAlD
Levetiracetam—ABCB1—seminal vesicle—urinary bladder cancer	0.00109	0.015	CbGeAlD
Levetiracetam—ABCB1—epithelium—urinary bladder cancer	0.000946	0.013	CbGeAlD
Levetiracetam—ABCB1—renal system—urinary bladder cancer	0.000877	0.0121	CbGeAlD
Levetiracetam—ABCB1—urethra—urinary bladder cancer	0.000862	0.0119	CbGeAlD
Levetiracetam—ABCB1—female reproductive system—urinary bladder cancer	0.000703	0.00967	CbGeAlD
Levetiracetam—ABCB1—vagina—urinary bladder cancer	0.000635	0.00874	CbGeAlD
Levetiracetam—ABCB1—lymph node—urinary bladder cancer	0.000411	0.00566	CbGeAlD
Levetiracetam—Stomatitis—Methotrexate—urinary bladder cancer	0.000229	0.00105	CcSEcCtD
Levetiracetam—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000228	0.00105	CcSEcCtD
Levetiracetam—Asthma—Doxorubicin—urinary bladder cancer	0.000228	0.00105	CcSEcCtD
Levetiracetam—Influenza—Doxorubicin—urinary bladder cancer	0.000228	0.00105	CcSEcCtD
Levetiracetam—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000227	0.00105	CcSEcCtD
Levetiracetam—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000225	0.00104	CcSEcCtD
Levetiracetam—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000225	0.00104	CcSEcCtD
Levetiracetam—Paraesthesia—Etoposide—urinary bladder cancer	0.000224	0.00103	CcSEcCtD
Levetiracetam—Weight increased—Epirubicin—urinary bladder cancer	0.000224	0.00103	CcSEcCtD
Levetiracetam—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000223	0.00103	CcSEcCtD
Levetiracetam—Weight decreased—Epirubicin—urinary bladder cancer	0.000223	0.00103	CcSEcCtD
Levetiracetam—Somnolence—Etoposide—urinary bladder cancer	0.000222	0.00102	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000222	0.00102	CcSEcCtD
Levetiracetam—Epistaxis—Methotrexate—urinary bladder cancer	0.000221	0.00102	CcSEcCtD
Levetiracetam—Vomiting—Thiotepa—urinary bladder cancer	0.000221	0.00102	CcSEcCtD
Levetiracetam—Infestation NOS—Epirubicin—urinary bladder cancer	0.000219	0.00101	CcSEcCtD
Levetiracetam—Drowsiness—Epirubicin—urinary bladder cancer	0.000219	0.00101	CcSEcCtD
Levetiracetam—Infestation—Epirubicin—urinary bladder cancer	0.000219	0.00101	CcSEcCtD
Levetiracetam—Rash—Thiotepa—urinary bladder cancer	0.000219	0.00101	CcSEcCtD
Levetiracetam—Bronchitis—Doxorubicin—urinary bladder cancer	0.000219	0.00101	CcSEcCtD
Levetiracetam—Dermatitis—Thiotepa—urinary bladder cancer	0.000219	0.00101	CcSEcCtD
Levetiracetam—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000219	0.00101	CcSEcCtD
Levetiracetam—Headache—Thiotepa—urinary bladder cancer	0.000218	0.001	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000218	0.001	CcSEcCtD
Levetiracetam—Decreased appetite—Etoposide—urinary bladder cancer	0.000217	0.001	CcSEcCtD
Levetiracetam—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000216	0.000998	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000216	0.000995	CcSEcCtD
Levetiracetam—Body temperature increased—Cisplatin—urinary bladder cancer	0.000215	0.000994	CcSEcCtD
Levetiracetam—Fatigue—Etoposide—urinary bladder cancer	0.000215	0.000993	CcSEcCtD
Levetiracetam—Stomatitis—Epirubicin—urinary bladder cancer	0.000214	0.000987	CcSEcCtD
Levetiracetam—Constipation—Etoposide—urinary bladder cancer	0.000213	0.000985	CcSEcCtD
Levetiracetam—Pain—Etoposide—urinary bladder cancer	0.000213	0.000985	CcSEcCtD
Levetiracetam—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000213	0.000984	CcSEcCtD
Levetiracetam—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000213	0.000984	CcSEcCtD
Levetiracetam—Neutropenia—Doxorubicin—urinary bladder cancer	0.000213	0.000983	CcSEcCtD
Levetiracetam—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000212	0.000978	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000212	0.000977	CcSEcCtD
Levetiracetam—Hepatitis—Methotrexate—urinary bladder cancer	0.00021	0.000971	CcSEcCtD
Levetiracetam—Asthenia—Gemcitabine—urinary bladder cancer	0.00021	0.000968	CcSEcCtD
Levetiracetam—Pharyngitis—Methotrexate—urinary bladder cancer	0.000209	0.000964	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000208	0.000958	CcSEcCtD
Levetiracetam—Weight increased—Doxorubicin—urinary bladder cancer	0.000207	0.000956	CcSEcCtD
Levetiracetam—Epistaxis—Epirubicin—urinary bladder cancer	0.000207	0.000955	CcSEcCtD
Levetiracetam—Pruritus—Gemcitabine—urinary bladder cancer	0.000207	0.000955	CcSEcCtD
Levetiracetam—Nausea—Thiotepa—urinary bladder cancer	0.000206	0.000953	CcSEcCtD
Levetiracetam—Weight decreased—Doxorubicin—urinary bladder cancer	0.000206	0.000951	CcSEcCtD
Levetiracetam—Sinusitis—Epirubicin—urinary bladder cancer	0.000206	0.00095	CcSEcCtD
Levetiracetam—Feeling abnormal—Etoposide—urinary bladder cancer	0.000206	0.00095	CcSEcCtD
Levetiracetam—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000205	0.000945	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000204	0.000942	CcSEcCtD
Levetiracetam—Pruritus—Fluorouracil—urinary bladder cancer	0.000203	0.000939	CcSEcCtD
Levetiracetam—Infestation—Doxorubicin—urinary bladder cancer	0.000203	0.000937	CcSEcCtD
Levetiracetam—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000203	0.000937	CcSEcCtD
Levetiracetam—Drowsiness—Doxorubicin—urinary bladder cancer	0.000203	0.000937	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000201	0.000929	CcSEcCtD
Levetiracetam—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000201	0.000927	CcSEcCtD
Levetiracetam—Diarrhoea—Gemcitabine—urinary bladder cancer	0.0002	0.000923	CcSEcCtD
Levetiracetam—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000199	0.000919	CcSEcCtD
Levetiracetam—Stomatitis—Doxorubicin—urinary bladder cancer	0.000198	0.000913	CcSEcCtD
Levetiracetam—Rhinitis—Epirubicin—urinary bladder cancer	0.000197	0.000911	CcSEcCtD
Levetiracetam—Body temperature increased—Etoposide—urinary bladder cancer	0.000197	0.000911	CcSEcCtD
Levetiracetam—Abdominal pain—Etoposide—urinary bladder cancer	0.000197	0.000911	CcSEcCtD
Levetiracetam—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000197	0.000911	CcSEcCtD
Levetiracetam—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000197	0.000911	CcSEcCtD
Levetiracetam—Hepatitis—Epirubicin—urinary bladder cancer	0.000197	0.000909	CcSEcCtD
Levetiracetam—Eye disorder—Methotrexate—urinary bladder cancer	0.000197	0.000908	CcSEcCtD
Levetiracetam—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000197	0.000908	CcSEcCtD
Levetiracetam—Asthenia—Cisplatin—urinary bladder cancer	0.000196	0.000902	CcSEcCtD
Levetiracetam—Pharyngitis—Epirubicin—urinary bladder cancer	0.000195	0.000902	CcSEcCtD
Levetiracetam—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000194	0.000893	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000192	0.000886	CcSEcCtD
Levetiracetam—Epistaxis—Doxorubicin—urinary bladder cancer	0.000191	0.000884	CcSEcCtD
Levetiracetam—Sinusitis—Doxorubicin—urinary bladder cancer	0.00019	0.000879	CcSEcCtD
Levetiracetam—Immune system disorder—Methotrexate—urinary bladder cancer	0.00019	0.000877	CcSEcCtD
Levetiracetam—Dizziness—Fluorouracil—urinary bladder cancer	0.00019	0.000877	CcSEcCtD
Levetiracetam—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00019	0.000876	CcSEcCtD
Levetiracetam—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000189	0.000874	CcSEcCtD
Levetiracetam—Diarrhoea—Cisplatin—urinary bladder cancer	0.000186	0.000861	CcSEcCtD
Levetiracetam—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000186	0.00086	CcSEcCtD
Levetiracetam—Alopecia—Methotrexate—urinary bladder cancer	0.000186	0.000858	CcSEcCtD
Levetiracetam—Vomiting—Gemcitabine—urinary bladder cancer	0.000186	0.000858	CcSEcCtD
Levetiracetam—Mental disorder—Methotrexate—urinary bladder cancer	0.000184	0.000851	CcSEcCtD
Levetiracetam—Rash—Gemcitabine—urinary bladder cancer	0.000184	0.000851	CcSEcCtD
Levetiracetam—Dermatitis—Gemcitabine—urinary bladder cancer	0.000184	0.00085	CcSEcCtD
Levetiracetam—Eye disorder—Epirubicin—urinary bladder cancer	0.000184	0.00085	CcSEcCtD
Levetiracetam—Hypersensitivity—Etoposide—urinary bladder cancer	0.000184	0.000849	CcSEcCtD
Levetiracetam—Malnutrition—Methotrexate—urinary bladder cancer	0.000183	0.000846	CcSEcCtD
Levetiracetam—Headache—Gemcitabine—urinary bladder cancer	0.000183	0.000845	CcSEcCtD
Levetiracetam—Vomiting—Fluorouracil—urinary bladder cancer	0.000183	0.000844	CcSEcCtD
Levetiracetam—Rhinitis—Doxorubicin—urinary bladder cancer	0.000183	0.000843	CcSEcCtD
Levetiracetam—Hepatitis—Doxorubicin—urinary bladder cancer	0.000182	0.000841	CcSEcCtD
Levetiracetam—Rash—Fluorouracil—urinary bladder cancer	0.000181	0.000837	CcSEcCtD
Levetiracetam—Dermatitis—Fluorouracil—urinary bladder cancer	0.000181	0.000836	CcSEcCtD
Levetiracetam—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000181	0.000835	CcSEcCtD
Levetiracetam—Headache—Fluorouracil—urinary bladder cancer	0.00018	0.000831	CcSEcCtD
Levetiracetam—Asthenia—Etoposide—urinary bladder cancer	0.000179	0.000827	CcSEcCtD
Levetiracetam—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000179	0.000827	CcSEcCtD
Levetiracetam—Immune system disorder—Epirubicin—urinary bladder cancer	0.000178	0.000821	CcSEcCtD
Levetiracetam—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000178	0.000819	CcSEcCtD
Levetiracetam—Back pain—Methotrexate—urinary bladder cancer	0.000177	0.000818	CcSEcCtD
Levetiracetam—Pruritus—Etoposide—urinary bladder cancer	0.000177	0.000815	CcSEcCtD
Levetiracetam—Alopecia—Epirubicin—urinary bladder cancer	0.000174	0.000803	CcSEcCtD
Levetiracetam—Nausea—Gemcitabine—urinary bladder cancer	0.000174	0.000802	CcSEcCtD
Levetiracetam—Vomiting—Cisplatin—urinary bladder cancer	0.000173	0.0008	CcSEcCtD
Levetiracetam—Vision blurred—Methotrexate—urinary bladder cancer	0.000173	0.000797	CcSEcCtD
Levetiracetam—Mental disorder—Epirubicin—urinary bladder cancer	0.000173	0.000796	CcSEcCtD
Levetiracetam—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000172	0.000795	CcSEcCtD
Levetiracetam—Rash—Cisplatin—urinary bladder cancer	0.000172	0.000793	CcSEcCtD
Levetiracetam—Dermatitis—Cisplatin—urinary bladder cancer	0.000172	0.000792	CcSEcCtD
Levetiracetam—Malnutrition—Epirubicin—urinary bladder cancer	0.000171	0.000791	CcSEcCtD
Levetiracetam—Diarrhoea—Etoposide—urinary bladder cancer	0.000171	0.000788	CcSEcCtD
Levetiracetam—Nausea—Fluorouracil—urinary bladder cancer	0.000171	0.000788	CcSEcCtD
Levetiracetam—Eye disorder—Doxorubicin—urinary bladder cancer	0.00017	0.000786	CcSEcCtD
Levetiracetam—Tension—Epirubicin—urinary bladder cancer	0.000168	0.000777	CcSEcCtD
Levetiracetam—Nervousness—Epirubicin—urinary bladder cancer	0.000167	0.000769	CcSEcCtD
Levetiracetam—Back pain—Epirubicin—urinary bladder cancer	0.000166	0.000766	CcSEcCtD
Levetiracetam—Dizziness—Etoposide—urinary bladder cancer	0.000165	0.000762	CcSEcCtD
Levetiracetam—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000165	0.00076	CcSEcCtD
Levetiracetam—Vertigo—Methotrexate—urinary bladder cancer	0.000165	0.00076	CcSEcCtD
Levetiracetam—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000164	0.000758	CcSEcCtD
Levetiracetam—Leukopenia—Methotrexate—urinary bladder cancer	0.000164	0.000757	CcSEcCtD
Levetiracetam—Nausea—Cisplatin—urinary bladder cancer	0.000162	0.000747	CcSEcCtD
Levetiracetam—Vision blurred—Epirubicin—urinary bladder cancer	0.000162	0.000746	CcSEcCtD
Levetiracetam—Alopecia—Doxorubicin—urinary bladder cancer	0.000161	0.000743	CcSEcCtD
Levetiracetam—Cough—Methotrexate—urinary bladder cancer	0.00016	0.000738	CcSEcCtD
Levetiracetam—Mental disorder—Doxorubicin—urinary bladder cancer	0.00016	0.000737	CcSEcCtD
Levetiracetam—Convulsion—Methotrexate—urinary bladder cancer	0.000159	0.000733	CcSEcCtD
Levetiracetam—Vomiting—Etoposide—urinary bladder cancer	0.000159	0.000733	CcSEcCtD
Levetiracetam—Malnutrition—Doxorubicin—urinary bladder cancer	0.000159	0.000732	CcSEcCtD
Levetiracetam—Agitation—Epirubicin—urinary bladder cancer	0.000158	0.000727	CcSEcCtD
Levetiracetam—Rash—Etoposide—urinary bladder cancer	0.000157	0.000727	CcSEcCtD
Levetiracetam—Dermatitis—Etoposide—urinary bladder cancer	0.000157	0.000726	CcSEcCtD
Levetiracetam—Headache—Etoposide—urinary bladder cancer	0.000156	0.000722	CcSEcCtD
Levetiracetam—Arthralgia—Methotrexate—urinary bladder cancer	0.000156	0.00072	CcSEcCtD
Levetiracetam—Chest pain—Methotrexate—urinary bladder cancer	0.000156	0.00072	CcSEcCtD
Levetiracetam—Myalgia—Methotrexate—urinary bladder cancer	0.000156	0.00072	CcSEcCtD
Levetiracetam—Tension—Doxorubicin—urinary bladder cancer	0.000156	0.000719	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000155	0.000715	CcSEcCtD
Levetiracetam—Nervousness—Doxorubicin—urinary bladder cancer	0.000154	0.000711	CcSEcCtD
Levetiracetam—Vertigo—Epirubicin—urinary bladder cancer	0.000154	0.000711	CcSEcCtD
Levetiracetam—Leukopenia—Epirubicin—urinary bladder cancer	0.000153	0.000708	CcSEcCtD
Levetiracetam—Back pain—Doxorubicin—urinary bladder cancer	0.000153	0.000708	CcSEcCtD
Levetiracetam—Confusional state—Methotrexate—urinary bladder cancer	0.000151	0.000696	CcSEcCtD
Levetiracetam—Cough—Epirubicin—urinary bladder cancer	0.00015	0.000691	CcSEcCtD
Levetiracetam—Vision blurred—Doxorubicin—urinary bladder cancer	0.00015	0.00069	CcSEcCtD
Levetiracetam—Convulsion—Epirubicin—urinary bladder cancer	0.000149	0.000686	CcSEcCtD
Levetiracetam—Infection—Methotrexate—urinary bladder cancer	0.000149	0.000686	CcSEcCtD
Levetiracetam—Nausea—Etoposide—urinary bladder cancer	0.000148	0.000684	CcSEcCtD
Levetiracetam—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000147	0.000677	CcSEcCtD
Levetiracetam—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000146	0.000676	CcSEcCtD
Levetiracetam—Chest pain—Epirubicin—urinary bladder cancer	0.000146	0.000674	CcSEcCtD
Levetiracetam—Myalgia—Epirubicin—urinary bladder cancer	0.000146	0.000674	CcSEcCtD
Levetiracetam—Arthralgia—Epirubicin—urinary bladder cancer	0.000146	0.000674	CcSEcCtD
Levetiracetam—Agitation—Doxorubicin—urinary bladder cancer	0.000146	0.000673	CcSEcCtD
Levetiracetam—Anxiety—Epirubicin—urinary bladder cancer	0.000145	0.000671	CcSEcCtD
Levetiracetam—Skin disorder—Methotrexate—urinary bladder cancer	0.000145	0.00067	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000145	0.000669	CcSEcCtD
Levetiracetam—Vertigo—Doxorubicin—urinary bladder cancer	0.000143	0.000658	CcSEcCtD
Levetiracetam—Anorexia—Methotrexate—urinary bladder cancer	0.000143	0.000658	CcSEcCtD
Levetiracetam—Leukopenia—Doxorubicin—urinary bladder cancer	0.000142	0.000655	CcSEcCtD
Levetiracetam—Confusional state—Epirubicin—urinary bladder cancer	0.000141	0.000651	CcSEcCtD
Levetiracetam—Infection—Epirubicin—urinary bladder cancer	0.000139	0.000642	CcSEcCtD
Levetiracetam—Cough—Doxorubicin—urinary bladder cancer	0.000138	0.000639	CcSEcCtD
Levetiracetam—Convulsion—Doxorubicin—urinary bladder cancer	0.000137	0.000634	CcSEcCtD
Levetiracetam—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000137	0.000633	CcSEcCtD
Levetiracetam—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000137	0.000632	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000136	0.000629	CcSEcCtD
Levetiracetam—Skin disorder—Epirubicin—urinary bladder cancer	0.000136	0.000627	CcSEcCtD
Levetiracetam—Insomnia—Methotrexate—urinary bladder cancer	0.000135	0.000624	CcSEcCtD
Levetiracetam—Chest pain—Doxorubicin—urinary bladder cancer	0.000135	0.000623	CcSEcCtD
Levetiracetam—Arthralgia—Doxorubicin—urinary bladder cancer	0.000135	0.000623	CcSEcCtD
Levetiracetam—Myalgia—Doxorubicin—urinary bladder cancer	0.000135	0.000623	CcSEcCtD
Levetiracetam—Anxiety—Doxorubicin—urinary bladder cancer	0.000135	0.000621	CcSEcCtD
Levetiracetam—Paraesthesia—Methotrexate—urinary bladder cancer	0.000134	0.00062	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000134	0.000619	CcSEcCtD
Levetiracetam—Anorexia—Epirubicin—urinary bladder cancer	0.000133	0.000616	CcSEcCtD
Levetiracetam—Somnolence—Methotrexate—urinary bladder cancer	0.000133	0.000614	CcSEcCtD
Levetiracetam—Dyspepsia—Methotrexate—urinary bladder cancer	0.000132	0.000608	CcSEcCtD
Levetiracetam—Confusional state—Doxorubicin—urinary bladder cancer	0.000131	0.000603	CcSEcCtD
Levetiracetam—Decreased appetite—Methotrexate—urinary bladder cancer	0.00013	0.0006	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000129	0.000596	CcSEcCtD
Levetiracetam—Fatigue—Methotrexate—urinary bladder cancer	0.000129	0.000595	CcSEcCtD
Levetiracetam—Infection—Doxorubicin—urinary bladder cancer	0.000129	0.000594	CcSEcCtD
Levetiracetam—Pain—Methotrexate—urinary bladder cancer	0.000128	0.00059	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000127	0.000588	CcSEcCtD
Levetiracetam—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000127	0.000586	CcSEcCtD
Levetiracetam—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000127	0.000585	CcSEcCtD
Levetiracetam—Insomnia—Epirubicin—urinary bladder cancer	0.000127	0.000584	CcSEcCtD
Levetiracetam—Skin disorder—Doxorubicin—urinary bladder cancer	0.000126	0.000581	CcSEcCtD
Levetiracetam—Paraesthesia—Epirubicin—urinary bladder cancer	0.000126	0.00058	CcSEcCtD
Levetiracetam—Somnolence—Epirubicin—urinary bladder cancer	0.000124	0.000574	CcSEcCtD
Levetiracetam—Anorexia—Doxorubicin—urinary bladder cancer	0.000123	0.00057	CcSEcCtD
Levetiracetam—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000123	0.000569	CcSEcCtD
Levetiracetam—Dyspepsia—Epirubicin—urinary bladder cancer	0.000123	0.000569	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000122	0.000564	CcSEcCtD
Levetiracetam—Decreased appetite—Epirubicin—urinary bladder cancer	0.000122	0.000561	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000121	0.000558	CcSEcCtD
Levetiracetam—Fatigue—Epirubicin—urinary bladder cancer	0.000121	0.000557	CcSEcCtD
Levetiracetam—Constipation—Epirubicin—urinary bladder cancer	0.00012	0.000552	CcSEcCtD
Levetiracetam—Pain—Epirubicin—urinary bladder cancer	0.00012	0.000552	CcSEcCtD
Levetiracetam—Abdominal pain—Methotrexate—urinary bladder cancer	0.000118	0.000546	CcSEcCtD
Levetiracetam—Body temperature increased—Methotrexate—urinary bladder cancer	0.000118	0.000546	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000118	0.000545	CcSEcCtD
Levetiracetam—Insomnia—Doxorubicin—urinary bladder cancer	0.000117	0.000541	CcSEcCtD
Levetiracetam—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000116	0.000537	CcSEcCtD
Levetiracetam—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000115	0.000532	CcSEcCtD
Levetiracetam—Somnolence—Doxorubicin—urinary bladder cancer	0.000115	0.000531	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000114	0.000528	CcSEcCtD
Levetiracetam—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000114	0.000526	CcSEcCtD
Levetiracetam—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000113	0.00052	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000112	0.000516	CcSEcCtD
Levetiracetam—Fatigue—Doxorubicin—urinary bladder cancer	0.000112	0.000515	CcSEcCtD
Levetiracetam—Pain—Doxorubicin—urinary bladder cancer	0.000111	0.000511	CcSEcCtD
Levetiracetam—Constipation—Doxorubicin—urinary bladder cancer	0.000111	0.000511	CcSEcCtD
Levetiracetam—Abdominal pain—Epirubicin—urinary bladder cancer	0.000111	0.000511	CcSEcCtD
Levetiracetam—Body temperature increased—Epirubicin—urinary bladder cancer	0.000111	0.000511	CcSEcCtD
Levetiracetam—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00011	0.000509	CcSEcCtD
Levetiracetam—Asthenia—Methotrexate—urinary bladder cancer	0.000107	0.000495	CcSEcCtD
Levetiracetam—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000107	0.000492	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000106	0.000489	CcSEcCtD
Levetiracetam—Pruritus—Methotrexate—urinary bladder cancer	0.000106	0.000488	CcSEcCtD
Levetiracetam—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000103	0.000476	CcSEcCtD
Levetiracetam—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000102	0.000472	CcSEcCtD
Levetiracetam—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000102	0.000472	CcSEcCtD
Levetiracetam—Diarrhoea—Methotrexate—urinary bladder cancer	0.000102	0.000472	CcSEcCtD
Levetiracetam—Asthenia—Epirubicin—urinary bladder cancer	0.0001	0.000463	CcSEcCtD
Levetiracetam—Pruritus—Epirubicin—urinary bladder cancer	9.9e-05	0.000457	CcSEcCtD
Levetiracetam—Dizziness—Methotrexate—urinary bladder cancer	9.89e-05	0.000456	CcSEcCtD
Levetiracetam—Diarrhoea—Epirubicin—urinary bladder cancer	9.57e-05	0.000442	CcSEcCtD
Levetiracetam—Hypersensitivity—Doxorubicin—urinary bladder cancer	9.54e-05	0.00044	CcSEcCtD
Levetiracetam—Vomiting—Methotrexate—urinary bladder cancer	9.51e-05	0.000439	CcSEcCtD
Levetiracetam—Rash—Methotrexate—urinary bladder cancer	9.43e-05	0.000435	CcSEcCtD
Levetiracetam—Dermatitis—Methotrexate—urinary bladder cancer	9.42e-05	0.000435	CcSEcCtD
Levetiracetam—Headache—Methotrexate—urinary bladder cancer	9.37e-05	0.000432	CcSEcCtD
Levetiracetam—Asthenia—Doxorubicin—urinary bladder cancer	9.29e-05	0.000429	CcSEcCtD
Levetiracetam—Dizziness—Epirubicin—urinary bladder cancer	9.25e-05	0.000427	CcSEcCtD
Levetiracetam—Pruritus—Doxorubicin—urinary bladder cancer	9.16e-05	0.000423	CcSEcCtD
Levetiracetam—Vomiting—Epirubicin—urinary bladder cancer	8.9e-05	0.000411	CcSEcCtD
Levetiracetam—Nausea—Methotrexate—urinary bladder cancer	8.88e-05	0.00041	CcSEcCtD
Levetiracetam—Diarrhoea—Doxorubicin—urinary bladder cancer	8.86e-05	0.000409	CcSEcCtD
Levetiracetam—Rash—Epirubicin—urinary bladder cancer	8.82e-05	0.000407	CcSEcCtD
Levetiracetam—Dermatitis—Epirubicin—urinary bladder cancer	8.81e-05	0.000407	CcSEcCtD
Levetiracetam—Headache—Epirubicin—urinary bladder cancer	8.77e-05	0.000405	CcSEcCtD
Levetiracetam—Dizziness—Doxorubicin—urinary bladder cancer	8.56e-05	0.000395	CcSEcCtD
Levetiracetam—Nausea—Epirubicin—urinary bladder cancer	8.31e-05	0.000384	CcSEcCtD
Levetiracetam—Vomiting—Doxorubicin—urinary bladder cancer	8.23e-05	0.00038	CcSEcCtD
Levetiracetam—Rash—Doxorubicin—urinary bladder cancer	8.16e-05	0.000377	CcSEcCtD
Levetiracetam—Dermatitis—Doxorubicin—urinary bladder cancer	8.16e-05	0.000376	CcSEcCtD
Levetiracetam—Headache—Doxorubicin—urinary bladder cancer	8.11e-05	0.000374	CcSEcCtD
Levetiracetam—Nausea—Doxorubicin—urinary bladder cancer	7.69e-05	0.000355	CcSEcCtD
